[Chemoembolization of symptomatic bone metastases: technical considerations and therapeutic effectiveness]
F Clarençon1, E Cormier, F Di Maria
1Service de neuroradiologie, groupe hospitalier Pitié-Salpêtrière, 47, boulevard de l'Hôpital, 75013 Paris, France. fredclare5@msn.com
Journal De Radiologie
|September 28, 2011
Summary
Chemoembolization delivers chemotherapy directly to bone metastases, improving local drug concentration. This effective treatment offers tumor response in 30-80% of cases and symptomatic relief in over 80%.
Area of Science:
- Oncology
- Interventional Radiology
- Pharmacology
Context:
- Bone metastases present a significant clinical challenge, often leading to pain and reduced quality of life.
- Current treatment modalities for bone metastases have limitations in achieving high local drug concentrations and efficacy.
- Chemoembolization offers a targeted approach to deliver chemotherapy directly to the tumor site.
Purpose:
- To review the indications, technical considerations, and effectiveness of chemoembolization for bone metastases.
- To elucidate the mechanism of action, including improved tissue impregnation and increased local chemotherapy concentration.
- To assess the clinical outcomes, including tumor response and symptomatic relief.
Summary:
- Chemoembolization involves intraarterial chemotherapy infusion followed by microparticle embolization for bone metastases.
- This technique enhances local chemotherapy delivery, leading to tumor response (30-80% of cases) and significant symptomatic relief (>80% of cases).
- The review covers procedural aspects, patient selection, and efficacy data.
Impact:
- Chemoembolization represents a valuable therapeutic option for managing bone metastases.
- Improved local drug delivery can enhance treatment efficacy and patient outcomes.
- This minimally invasive procedure offers a promising strategy for palliative care and tumor control in bone metastases.
